Product Name

  • Name

    Medroxyprogesterone 17-acetate

  • EINECS 200-757-9
  • CAS No. 71-58-9
  • Article Data32
  • CAS DataBase
  • Density 1.13 g/cm3
  • Solubility <0.1 g/100 mL at 23 °C in water
  • Melting Point 206-207 °C(lit.)
  • Formula C24H34O4
  • Boiling Point 496.4 °C at 760 mmHg
  • Molecular Weight 386.532
  • Flash Point 213.2 °C
  • Transport Information
  • Appearance white crystalline powder
  • Safety 22-36/37/39-45
  • Risk Codes 40-48
  • Molecular Structure Molecular Structure of 71-58-9 (Medroxyprogesterone 17-acetate)
  • Hazard Symbols HarmfulXn
  • Synonyms Pregn-4-ene-3,20-dione,17-hydroxy-6a-methyl-, acetate(7CI,8CI);Progesterone, 17-hydroxy-6a-methyl-, acetate (6CI);17a-Acetoxy-6a-methylprogesterone;17a-Hydroxy-6a-methyl-4-pregnene-3,20-dione17-acetate;17a-Hydroxy-6a-methylprogesteroneacetate;6a-Methyl-17-acetoxyprogesterone;6a-Methyl-17a-acetoxy-D4-pregnene-3,20-dione;6a-Methyl-17a-acetoxypregn-4-ene-3,20-dione;Amen;CBP 1011;Clinovir;Colirest;Curretab;Cycrin;DMPA;Depo-Prodasone;Depo-Ralovera;Depo-promone;Depomedroxyprogesterone acetate;Farlutal;Farlutin;Lutoral;Medroprogesterone acetate;
  • PSA 60.44000
  • LogP 4.51270

Synthetic route

17α-Acetoxy-6-methylene-pregn-4-ene-3,20-dione
32634-95-0

17α-Acetoxy-6-methylene-pregn-4-ene-3,20-dione

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
With ethanol; 5%-palladium/activated carbon In cyclohexene at 75 - 78℃; for 5h; Reagent/catalyst; Temperature;87.5%
With sodium acetate; cyclohexene; palladium on activated charcoal In ethanol; water Heating / reflux;
3-cycloethylenedioxy-6-methyl-17α-acetoxy-pregn-5-ene-20-one
809-01-8

3-cycloethylenedioxy-6-methyl-17α-acetoxy-pregn-5-ene-20-one

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
With silica gel; copper(II) sulfate In chloroform for 2h; Heating;81%
6-methylpregn-5-ene-3β,17α-diol-20-one 17-acetate
2381-48-8

6-methylpregn-5-ene-3β,17α-diol-20-one 17-acetate

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
With cyclohexanone; aluminum isopropoxide; toluene
With aluminum isopropoxide
3,17-diacetoxy-6-methyl-pregna-3,5-dien-20-one
986-96-9

3,17-diacetoxy-6-methyl-pregna-3,5-dien-20-one

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
With hydrogenchloride
Medroxyprogesterone
520-85-4

Medroxyprogesterone

acetic anhydride
108-24-7

acetic anhydride

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
With toluene-4-sulfonic acid; acetic acid
6-Formil-3-(2'-chloro-etossi)-Δ3,5-pregnadien-17α-ol-20-one acetato

6-Formil-3-(2'-chloro-etossi)-Δ3,5-pregnadien-17α-ol-20-one acetato

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In methanol
3β-acetoxy-17α-hydroxy-5-pregnen-20-one
1863-39-4

3β-acetoxy-17α-hydroxy-5-pregnen-20-one

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: benzene; toluene-4-sulfonic acid
2: peroxybenzoic acid; chloroform
3: benzene; diethyl ether
4: aqueous methanol.H2SO4
5: CrO3; pyridine
6: aqueous HCl
7: acetic acid; toluene-4-sulfonic acid
View Scheme
3β,5,17-trihydroxy-6β-methyl-5α-pregnan-20-one
113665-92-2

3β,5,17-trihydroxy-6β-methyl-5α-pregnan-20-one

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: CrO3; pyridine
2: aqueous HCl
3: acetic acid; toluene-4-sulfonic acid
View Scheme
5,17-dihydroxy-6β-methyl-5α-pregnane-3,20-dione
23706-51-6

5,17-dihydroxy-6β-methyl-5α-pregnane-3,20-dione

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous HCl
2: acetic acid; toluene-4-sulfonic acid
View Scheme
Multi-step reaction with 2 steps
1: HCl; CHCl3
2: acetic acid; toluene-4-sulfonic acid
View Scheme
Multi-step reaction with 3 steps
1: pyridine; aq. NaOH solution
2: HCl; CHCl3
3: acetic acid; toluene-4-sulfonic acid
View Scheme
20,20-ethanediyldioxy-6β-methyl-5α-pregnane-3β,5,17-triol
19699-76-4

20,20-ethanediyldioxy-6β-methyl-5α-pregnane-3β,5,17-triol

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: aqueous methanol.H2SO4
2: CrO3; pyridine
3: aqueous HCl
4: acetic acid; toluene-4-sulfonic acid
View Scheme
3β-acetoxy-20,20-ethanediyldioxy-pregn-5-en-17-ol
19699-74-2

3β-acetoxy-20,20-ethanediyldioxy-pregn-5-en-17-ol

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: peroxybenzoic acid; chloroform
2: benzene; diethyl ether
3: aqueous methanol.H2SO4
4: CrO3; pyridine
5: aqueous HCl
6: acetic acid; toluene-4-sulfonic acid
View Scheme
3β-acetoxy-20,20-ethanediyldioxy-5,6α-epoxy-5α-pregnan-17-ol
19699-75-3

3β-acetoxy-20,20-ethanediyldioxy-5,6α-epoxy-5α-pregnan-17-ol

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: benzene; diethyl ether
2: aqueous methanol.H2SO4
3: CrO3; pyridine
4: aqueous HCl
5: acetic acid; toluene-4-sulfonic acid
View Scheme
6-methylpregn-5-ene-3β,17α-diol-20-one diacetate
60446-57-3

6-methylpregn-5-ene-3β,17α-diol-20-one diacetate

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous methanol. HCl
2: cyclohexanone; aluminium isopropylate; toluene
View Scheme
17-hydroxy-6β-methyl-pregn-4-ene-3,20-dione
80996-18-5

17-hydroxy-6β-methyl-pregn-4-ene-3,20-dione

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: HCl; CHCl3
2: acetic acid; toluene-4-sulfonic acid
View Scheme
3,3;20,20-bis-ethanediyldioxy-6β-methyl-5α-pregnane-5,17-diol
3386-01-4

3,3;20,20-bis-ethanediyldioxy-6β-methyl-5α-pregnane-5,17-diol

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetone / saure Hydrolyse
2: HCl; CHCl3
3: acetic acid; toluene-4-sulfonic acid
View Scheme
Multi-step reaction with 4 steps
1: acetone / saure Hydrolyse
2: pyridine; aq. NaOH solution
3: HCl; CHCl3
4: acetic acid; toluene-4-sulfonic acid
View Scheme
17-hydroxy-5-pregnene-3,20-dione 3,20-bisethylene ketal
3386-00-3

17-hydroxy-5-pregnene-3,20-dione 3,20-bisethylene ketal

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: peroxyacetic acid
2: tetrahydrofuran
3: acetone / saure Hydrolyse
4: HCl; CHCl3
5: acetic acid; toluene-4-sulfonic acid
View Scheme
Multi-step reaction with 6 steps
1: peroxyacetic acid
2: tetrahydrofuran
3: acetone / saure Hydrolyse
4: pyridine; aq. NaOH solution
5: HCl; CHCl3
6: acetic acid; toluene-4-sulfonic acid
View Scheme
3,3;20,20-bis-ethanediyldioxy-5,6α-epoxy-5α-pregnan-17-ol
3496-78-4

3,3;20,20-bis-ethanediyldioxy-5,6α-epoxy-5α-pregnan-17-ol

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: tetrahydrofuran
2: acetone / saure Hydrolyse
3: HCl; CHCl3
4: acetic acid; toluene-4-sulfonic acid
View Scheme
Multi-step reaction with 5 steps
1: tetrahydrofuran
2: acetone / saure Hydrolyse
3: pyridine; aq. NaOH solution
4: HCl; CHCl3
5: acetic acid; toluene-4-sulfonic acid
View Scheme
Medroxyprogesterone
520-85-4

Medroxyprogesterone

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: acetic acid; toluene-4-sulfonic acid
2: methanol.HCl
View Scheme
3β-Formyloxy-6-methyl-Δ5-pregnen-17α-acetoxy-20-on

3β-Formyloxy-6-methyl-Δ5-pregnen-17α-acetoxy-20-on

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. HCl
2: Al(OiPr)3
View Scheme
2-methyl-1H-indole
95-20-5

2-methyl-1H-indole

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

C33H43NO4
1233478-27-7

C33H43NO4

Conditions
ConditionsYield
With rhodium(III) chloride hydrate In methanol for 2.5h; Michael addition; Reflux; diastereoselective reaction;95%
1-methylindole
603-76-9

1-methylindole

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

C33H43NO4
1233478-26-6

C33H43NO4

Conditions
ConditionsYield
With rhodium(III) chloride hydrate In methanol for 6h; Michael addition; Reflux; diastereoselective reaction;78%
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

11β-hydroxy-medroxyprogesterone acetate

11β-hydroxy-medroxyprogesterone acetate

Conditions
ConditionsYield
With Absidia griseollavar. igachii In ethanol at 25℃; for 240h; Reagent/catalyst; Temperature; Microbiological reaction; regioselective reaction;63%
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

17α-acetyloxy-6-methylpregna-3,5-dien-20-one

17α-acetyloxy-6-methylpregna-3,5-dien-20-one

Conditions
ConditionsYield
Stage #1: Medroxyprogesterone acetate With C19H26ClIrN3O(1+)*Cl(1-) In water at 80℃; for 0.166667h;
Stage #2: With formic acid In water at 80℃; for 4h; regioselective reaction;
62%
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Megestrol acetate
595-33-5

Megestrol acetate

Conditions
ConditionsYield
With chloranil
With 2-methyl-propan-1-ol; chloranil Heating;
With chloranil
Multi-step reaction with 2 steps
1: TsOH / dioxane
2: (tBuO)2CrO2, Ac2O / CCl4
View Scheme
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

17-acetoxy-6α-methyl-pregna-1,4-diene-3,20-dione
151-68-8

17-acetoxy-6α-methyl-pregna-1,4-diene-3,20-dione

Conditions
ConditionsYield
With pyridine; selenium(IV) oxide; tert-butyl alcohol
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

Medroxyprogesterone
520-85-4

Medroxyprogesterone

Conditions
ConditionsYield
With potassium hydroxide
With water; sodium hydroxide In methanol for 5h; Reflux;
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

chloranil
118-75-2

chloranil

acetic acid
64-19-7

acetic acid

ethyl acetate
141-78-6

ethyl acetate

Megestrol acetate
595-33-5

Megestrol acetate

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

chloranil
118-75-2

chloranil

tert-butyl alcohol
75-65-0

tert-butyl alcohol

Megestrol acetate
595-33-5

Megestrol acetate

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

propionic acid anhydride
123-62-6

propionic acid anhydride

17-acetoxy-6-methyl-3-propionyloxy-pregna-3,5-dien-20-one
114552-99-7

17-acetoxy-6-methyl-3-propionyloxy-pregna-3,5-dien-20-one

Conditions
ConditionsYield
With toluene-4-sulfonic acid
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

A

anti-6α-Methyl-17α-acetoxy-Δ4-pregnen-20-on-3-N-chlorimin

anti-6α-Methyl-17α-acetoxy-Δ4-pregnen-20-on-3-N-chlorimin

B

syn-6α-Methyl-17α-acetoxy-Δ4-pregnen-20-on-3-N-chlorimin

syn-6α-Methyl-17α-acetoxy-Δ4-pregnen-20-on-3-N-chlorimin

Conditions
ConditionsYield
(i) MeNH2, MeOH, (ii) aq. Ca(OCl)2, NH3, OTs; Multistep reaction;
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

trichloroacetic acid anhydride
4124-31-6

trichloroacetic acid anhydride

17α-Acetoxy-3-trichloracetoxy-6-methyl-Δ3,5-pregnadien-20-on
22223-98-9

17α-Acetoxy-3-trichloracetoxy-6-methyl-Δ3,5-pregnadien-20-on

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

6α-methylpregn-4-ene-3β,17α-diol-20-one 17-acetate
57-16-9

6α-methylpregn-4-ene-3β,17α-diol-20-one 17-acetate

Conditions
ConditionsYield
With lithium tri(t-butoxy)aluminum hydride In tetrahydrofuran at 0℃;
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

A

17α-acetoxy-3α-hydroxy-6α-methyl-5α-pregnan-20-one
113891-97-7

17α-acetoxy-3α-hydroxy-6α-methyl-5α-pregnan-20-one

B

17α-acetoxy-3β-hydroxy-6α-methyl-5α-pregnan-20-one
113891-98-8

17α-acetoxy-3β-hydroxy-6α-methyl-5α-pregnan-20-one

C

17α-acetoxy-3α-hydroxy-6α-methyl-5β-pregnan-20-one
71315-38-3

17α-acetoxy-3α-hydroxy-6α-methyl-5β-pregnan-20-one

D

17α-acetoxy-3β-hydroxy-6α-methyl-5β-pregnan-20-one
71315-40-7

17α-acetoxy-3β-hydroxy-6α-methyl-5β-pregnan-20-one

Conditions
ConditionsYield
With hydrogen; Rh on carbon In ethanol; acetic acid for 48h; Yield given. Yields of byproduct given;
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

17α-acetoxy-6α-methyl-5β-pregnane-3,20-dione
69688-15-9

17α-acetoxy-6α-methyl-5β-pregnane-3,20-dione

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethyl acetate
With hydrogen; Lindlar's catalyst In pyridine for 24h;6.9 g
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

6α-methylpregn-4-ene-3α,17α-diol-20-one 17-acetate
113846-17-6

6α-methylpregn-4-ene-3α,17α-diol-20-one 17-acetate

Conditions
ConditionsYield
With lithium tri-sec-butyl(hydrido)borate In tetrahydrofuran at -78℃;
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

3-Cloro-6-metil-Δ3,5-pregnadien-17α-ol-20-one acetato

3-Cloro-6-metil-Δ3,5-pregnadien-17α-ol-20-one acetato

Conditions
ConditionsYield
With N,N-dimethyl-formamide; trichlorophosphate
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

A

3α-Hydroxy-6α-methyl-5β-androstan-17-on

3α-Hydroxy-6α-methyl-5β-androstan-17-on

B

3β-Hydroxy-6α-methyl-5α-androstan-17-on

3β-Hydroxy-6α-methyl-5α-androstan-17-on

Conditions
ConditionsYield
(i) H2, Pd-C, AcOEt, (ii) LiAlH4, Et2O, (iii) aq. NaIO4, AcOH, EtOH; Multistep reaction;
formaldehyd
50-00-0

formaldehyd

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

thiophenol
108-98-5

thiophenol

17α-Acetoxy-6β-methyl-4-phenylmercaptomethyl-progesteron

17α-Acetoxy-6β-methyl-4-phenylmercaptomethyl-progesteron

Conditions
ConditionsYield
With triethylamine In ethanol
Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

trimethyl orthoformate
149-73-5

trimethyl orthoformate

3-Methoxy-17α-acetoxy-6-methyl-pregnadien-(3,5)-on-(20)
1104-99-0

3-Methoxy-17α-acetoxy-6-methyl-pregnadien-(3,5)-on-(20)

Conditions
ConditionsYield
With toluene-4-sulfonic acid In 1,4-dioxane
pyridine
110-86-1

pyridine

selenium(IV) oxide
7446-08-4

selenium(IV) oxide

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

tert-butyl alcohol
75-65-0

tert-butyl alcohol

17-acetoxy-6α-methyl-pregna-1,4-diene-3,20-dione
151-68-8

17-acetoxy-6α-methyl-pregna-1,4-diene-3,20-dione

Medroxyprogesterone acetate
71-58-9

Medroxyprogesterone acetate

17α-acetoxy-3α-hydroxy-6α-methyl-5α-pregnan-20-one
113891-97-7

17α-acetoxy-3α-hydroxy-6α-methyl-5α-pregnan-20-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: lithium tri-t-butoxyaluminium hydride / tetrahydrofuran / 0 °C
2: 47 mg / H2 / Rh-C / ethanol; acetic acid / 48 h
View Scheme

Medroxyprogesterone 17-acetate Chemical Properties

The Molecular Structure of Medroxyprogesterone Acetate (CAS NO.71-58-9):

Empirical Formula: C24H34O4
Molecular Weight: 386.5244
Appearance: white crystalline powder
Nominal Mass: 386 
Average Mass: 386.5244
Monoisotopic Mass: 386.24571
Index of Refraction: 1.538
Molar Refractivity: 106.71 cm3
Molar Volume: 340.8 cm3 
Surface Tension: 43.2 dyne/cm
Density: 1.13 g/cm3
Flash Point: 213.2 °C
Enthalpy of Vaporization: 76.41 kJ/mol
Boiling Point: 496.4 °C at 760 mmHg
Vapour Pressure: 5.44E-10 mmHg at 25 °C 
Water Solubility:  <0.1 g/100 mL at 23 °C 
Melting Point: 206-207 °C 
Stability: Stable, but weakly air and light sensitive. Incompatible with strong oxidizing agents
Classification Code: Antineoplastic Agents; Antineoplastic agents, hormonal; Contraceptive Agents; Contraceptive agents, female; Contraceptive agents, male; Drug / Therapeutic Agent; Hormone; Human Data; Mutation data; Progestin; Reproductive Control Agents; Reproductive Effect; Tumor data
IUPAC Name:  [(6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate   
Synonyms: (6-Alpha)-17-(acetyloxy)-6-methylpreg-4-ene-3,20-dione ; 17-(Acetyloxy)-6-methyl-(6-alpha)-pregn-4-ene-20-dione ; 17-(Acetyloxy)-6-methyl-20-dion(6alpha)-pregn-4-ene- ; 17-Acetoxy-6-alpha-methylprogesterone ; 17-Alpha-hydroxy-6-alpha-methylpregn-4-ene-3,20-dioneacetate ; 17-Alpha-hydroxy-6-alpha-methyl-progesteronacetate ; 17-Alpha-hydroxy-6-alpha-methylprogesteroneacetate ; 17-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dioneacetate  

Medroxyprogesterone 17-acetate Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 oral > 5gm/kg (5000mg/kg)   Drugs in Japan Vol. -, Pg. 1196, 1990.
mouse LD50 intraperitoneal > 1500mg/kg (1500mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984.
mouse LD50 oral > 16gm/kg (16000mg/kg) ENDOCRINE: ADRENAL CORTEX HYPOPLASIA Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984.
mouse LD50 subcutaneous > 1500mg/kg (1500mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984.
rat LD50 intraperitoneal > 900mg/kg (900mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984.
rat LD50 oral > 6400mg/kg (6400mg/kg) LIVER: OTHER CHANGES Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984.
rat LD50 subcutaneous > 900mg/kg (900mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 18, Pg. 6135, 1984.
women TDLo intravenous 10mg/kg (10mg/kg) SENSE ORGANS AND SPECIAL SENSES: INCREASED INTRAOCULAR PRESSURE: EYE Advances in Planned Parenthood. Vol. 8, Pg. 103, 1972.
women TDLo intravenous 21mg/kg (21mg/kg) SENSE ORGANS AND SPECIAL SENSES: INCREASED INTRAOCULAR PRESSURE: EYE Advances in Planned Parenthood. Vol. 8, Pg. 103, 1972.

Medroxyprogesterone 17-acetate Safety Profile

Hazard Codes: HarmfulXn
Risk Statements: 40-48 
R40: Limited evidence of a carcinogenic effect
R48: Danger of serious damage to health by prolonged exposur
Safety Statements: 22-36/37/39-45 
S22: Do not breathe dust
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection

S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
WGK Germany: 3
RTECS: TU5010000

Medroxyprogesterone 17-acetate Specification

Incompatibilities: Flammable and/or toxic gases are generated by combination with with alkali metals, nitrides, and strong reducing agents Reacts with oxoacids and carboxylic acids to form esters plus water Incompatible with oxidizing agents.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View